CXCL12 and neoplasm: The premise of this therapeutic approach relied on the initial accumulation of S&D@Ag2Se in the tumor, where under low pH the DOX could be released; at the same time, SDF-1α would act as a beacon71 – selectively guiding the NK-92 cells towards the tumor site to induce cancer cell death (Fig. 6 – A1).